Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-07-31
1991-07-09
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514253, 514256, 514278, 514338, 514341, 514395, 514398, 544333, 544406, 546 15, 546271, 546278, 548323, 548329, 548337, 548339, A61K 31415, A61K 31495, C07D23528, C07D40112
Patent
active
050306448
ABSTRACT:
Imidazole compounds including imidazoles and imidazolium salts, and their use as transglutaminase inhibitors are disclosed.
REFERENCES:
patent: 2527265 (1950-10-01), Kendall et al.
patent: 4182769 (1980-01-01), Cherkofsky et al.
patent: 4218476 (1980-08-01), Joensson et al.
patent: 4265898 (1981-05-01), Horstmann et al.
patent: 4814329 (1989-03-01), Harsanyi et al.
Kister et al., Can. J. Chem. 57,813 (1979).
Kister et al., Can. J. Chem. 57,822 (1979).
Baldwin John J.
Claremon David A.
Remy David C.
Lee Mary C.
Merck & Co. , Inc.
Miltenberger Lenora A.
Pfeiffer Hesna J.
Robertson Alice O.
LandOfFree
Imidazole compounds and their use as transglutaminase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole compounds and their use as transglutaminase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole compounds and their use as transglutaminase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-618439